Skip to main navigation
Alumis Inc. Logo Skip to main content
  • About
    • Mission
    • Leadership
    • Board of Directors
  • Science
    • Approach
    • About TYK2
    • Anti-IGF-1R
    • Publications and Posters
  • Patients
    • Clinical Trials
    • Psoriasis
    • Lupus (SLE)
    • Thyroid Eye Disease (TED)
    • Patient Resources
    • Expanded Access Policy
  • Pipeline
    • Pipeline
    • Envudeucitinib for Psoriasis
    • Envudeucitinib for SLE
    • Lonigutamab
    • A-005
  • Careers
    • Job Opportunities
    • Values
    • Spotlights
    • Benefits
    • Life at Alumis
  • Investors
    • News
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Financials & Filings
    • IR Resources

SEC Filing Details

Document Details

Form
4
Filing Date
Nov 25, 2025
Document Date
Nov 21, 2025
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Alumis Inc.
Issuer
ALUMIS INC.
Filer
FORESITE LABS, LLC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR
  • Overview
  • News
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • More
    • Home
    • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historic Price Lookup
        • Investment Calculator
        • Analyst Coverage
      • Corporate Governance
        • Documents & Charters
        • Management Team
        • Board of Directors
        • Committee Composition
      • Financials & Filings
        • SEC Filings
      • IR Resources
        • Investor FAQs
        • Email Alerts
        • Contact IR
    • About
      • Mission
      • Leadership
      • Board of Directors
    • Our Approach
      • Why It Matters
    • Pipeline
      • About TYK2
      • ESK-001
      • A-005
      • Publications
    • Careers
      • Job Opportunities
      • Values
      • Life at Alumis
    • Contact
    Alumis Inc. Logo

    Alumis Inc.
    280 East Grand Avenue
    South San Francisco
    CA 94080
    (650) 231-6625

    Contact

    Business Development
    bd@alumis.com

    General Inquiries
    info@alumis.com

    Careers
    careers@alumis.com

    Medical Affairs
    Contact our Medical Affairs Team

    • LinkedIn
    • Twitter
    • Privacy Policy
    © 2026 Alumis Inc. All rights reserved.
    Website Design: Hane Chow, Inc.